[HTML][HTML] Repeated application of autologous bone marrow-derived lineage-negative stem/progenitor cells—focus on immunological pathways in patients with ALS
B Baumert, A Sobuś, M Gołąb-Janowska… - Cells, 2020 - mdpi.com
Therapeutic interventions in amyotrophic lateral sclerosis (ALS) are still far from satisfying.
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …
Repeated Application of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells-Focus on Immunological Pathways in Patients with ALS
B Baumert, A Sobuś, M Gołąb-Janowska… - Cells, 2020 - pubmed.ncbi.nlm.nih.gov
Therapeutic interventions in amyotrophic lateral sclerosis (ALS) are still far from satisfying.
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …
Repeated Application of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells—Focus on Immunological Pathways in Patients with ALS.
B Baumert, A Sobuś, M Gołąb-Janowska… - Cells (2073 …, 2020 - search.ebscohost.com
Therapeutic interventions in amyotrophic lateral sclerosis (ALS) are still far from satisfying.
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …
[PDF][PDF] Repeated Application of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells—Focus on Immunological Pathways in Patients with ALS
B Baumert, A Sobus, M Gołab-Janowska… - 2021 - ppm.pum.edu.pl
Therapeutic interventions in amyotrophic lateral sclerosis (ALS) are still far from satisfying.
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …
Repeated Application of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells-Focus on Immunological Pathways in Patients with ALS.
B Baumert, A Sobuś, M Gołąb-Janowska… - Cells, 2020 - europepmc.org
Therapeutic interventions in amyotrophic lateral sclerosis (ALS) are still far from satisfying.
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …
Repeated Application of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells—Focus on Immunological Pathways in Patients with ALS
B Baumert, A Sobuś, M Gołąb-Janowska… - 2020 - agris.fao.org
Therapeutic interventions in amyotrophic lateral sclerosis (ALS) are still far from satisfying.
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …
[PDF][PDF] Repeated Application of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells—Focus on Immunological Pathways in Patients with ALS
B Baumert, A Sobus, M Gołab-Janowska… - ppm.edu.pl
Therapeutic interventions in amyotrophic lateral sclerosis (ALS) are still far from satisfying.
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …
[HTML][HTML] Repeated Application of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells—Focus on Immunological Pathways in Patients with ALS
B Baumert, A Sobuś, M Gołąb-Janowska… - Cells, 2020 - ncbi.nlm.nih.gov
Therapeutic interventions in amyotrophic lateral sclerosis (ALS) are still far from satisfying.
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …
[PDF][PDF] Repeated Application of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells—Focus on Immunological Pathways in Patients with ALS
B Baumert, A Sobuś, M Gołąb-Janowska… - researchgate.net
Therapeutic interventions in amyotrophic lateral sclerosis (ALS) are still far from satisfying.
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …
Repeated Application of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells—Focus on Immunological Pathways in Patients with ALS
B Baumert, A Sobuś, M Gołąb-Janowska… - Cells, 2020 - search.proquest.com
Therapeutic interventions in amyotrophic lateral sclerosis (ALS) are still far from satisfying.
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …
Immune modulating procedures raise hopes for slowing the disease progression. Stem cell …